What Chronic Lymphocytic Leukemia Patients Should Know in 2025 with Alvaro Alencar, MD
Join us for this webinar with Dr. Alvaro Alencar to get the most up-to-date information on living with CLL in 2025. This is a great opportunity to learn from and ask questions to a top CLL specialist.
Dalton introduces the agenda of the event and featured speaker Dr. Alvaro Alencar
Dr. Alvaro Alencar shares the most up-to-date information on living with CLL in 2025
Type your questions in the chat, we will answer them!
Alvaro Alencar, M.D.
Dr. Alencar is an Associate Professor of Clinical Medicine and the Chief Medical Officer at University of Miami Sylvester Comprehensive Cancer Center. He is a member of the lymphoma program at Sylvester and the lymphoma committee at the Alliance for Clinical Trials in Oncology. As the hematology section lead for the Sylvester’s Global Oncology Program, Dr. Alencar serves as an important bridge to the United States for Latin American hematologists being a constant presence in meetings, lectures, as well as tumor board and second opinions. These collaborations have led to a large multinational study evaluating the impact of genetic changes and ancestry on outcomes of Hispanic patients with blood disorders.
Dalton Bean
Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.